insights_auto
Why is GMAB up 3,78%?
Dive Deeperchevron_right
GMAB:CPH
Genmab A/S
2 445,00 DKK
arrow_upward
+3,78%(+89,00) 1D
9-окт., 17:00:00 GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
2 425,00 DKK
High
2 472,00 DKK
Low
2 400,00 DKK
Mkt. cap
152,72 млд
Avg. vol.
125,50 миң
Volume
96,37 миң
52-wk high
2 603,00 DKK
52-wk low
1 512,00 DKK
Shares outstanding
62,41 млн
No. of employees
3 миң
Open
2 425,00 DKK
High
2 472,00 DKK
Low
2 400,00 DKK
Mkt. cap
152,72 млд
Avg. vol.
125,50 миң
Volume
96,37 миң
52-wk high
2 603,00 DKK
52-wk low
1 512,00 DKK
Shares outstanding
62,41 млн
No. of employees
3 миң
News stories
From web sources and news partners
The Globe and Mail
·
2 күн мурун
Genmab (GMAB) Receives a Buy from Truist Financial
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3,12 миң
Founded1998-ж., 11-июн.
Headquarters-
Sector-
Websitegenmab.com